Motion correction has potential to affect diagnosis or patient care.
There was better quantification and detection of PET-avid lesions with the addition of a motion correction algorithm, according to a study published in the Journal of Nuclear Medicine.
Researchers from the United Kingdom sought to determine the ability of their joint PET/MRI-based predictive motion model to correct respiratory motion in PET, demonstrating that the algorithm could improve lesion detectability and quantitation and reduce image artifacts.
Forty-two clinical PET/MRI patient datasets containing 162 PET-avid lesions were included in the study. The researchers used multiple tracers and multiple organ locations to apply their motion correction method to the datasets. Quantitative changes were calculated using SUV changes in avid lesions. Lesion detectability changes were explored with a study; two radiologists identified lesions in uncorrected and motion-corrected images and provided confidence scores.
The results showed mean increases of 12.4% for SUVpeak and 17.6% for SUVmax after motion correction were found. In the detectability study, confidence scores for detecting avid lesions increased, with a rise in mean score from 2.67 to 3.01 (of 4) after motion correction and a rise in detection rate from 74% to 84%. Of 162 confirmed lesions, 49 showed an increase in all three metrics-SUVpeak, SUVmax, and combined reader confidence score-whereas only two lesions showed a decrease.
The researchers also presented clinical case studies that demonstrated the effect of respiratory motion correction of PET data on patient management, with increased numbers of detected lesions, improved lesion sharpness and localization, and reduced attenuation-based artifacts.
They concluded that there were significant improvements in quantification and detection of PET-avid lesions, with specific case study examples showing where motion correction has the potential to affect diagnosis or patient care.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
Surveillance Breast MRI Associated with Lower Risks of Advanced Second Breast Cancers
January 8th 2025After propensity score matching in a study of over 3,000 women with a personal history of breast cancer, researchers found that surveillance breast MRI facilitated a 59 percent lower risk in advanced presentations of second breast cancers.
Abbreviated MRI for Hepatocellular Carcinoma: What a New Meta-Analysis Reveals
January 6th 2025For hepatocellular carcinoma screening, a 19-study meta-analysis found the abbreviated MRI sequencing protocol of T2-weighted MRI, diffusion-weighted imaging (DWI) and hepatobiliary phase (HBP) imaging offered 88 percent sensitivity and 93 percent specificity.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.